Newly Discovered Late Clinical Stage BioPharma Vendor with Potentially Revolutionary Breakthroughs & 4 Analyst Briefs on Comp...

Nate’s Food Co. (OTCBB: NHMD) makes pancake and waffle batter in a ready-to-use, pre-mixed pancake and waffle batter delivered in a pressurized can.

The company’s founder has a history of bringing new products to market. Read about the company’s outlook for this new product, new products in the pipeline and potential markets in the report here, at the link: http://bit.ly/-NHMD-AnalystBrief

ERHC ENERGY, Inc. (OTCQB: ERHE) is a Houston-based independent oil and gas company focused on growth through high impact exploration in Africa and the development of undeveloped and marginal oil and gas fields.

The company revealed potential for its partnership with CESPA at some of its interests in Africa. Get the details in the report at the following link: http://bit.ly/-ERHE-AnalystBrief

Implant Sciences Corp. (OTCQB: IMSC) is involved in next generation Explosives Trace Detection ("ETD") technology. In October 2013, the Company became the third ETD manufacturer, and the sole American-owned company, to currently have product qualification from the US Transportation Security Administration.

Get more details of the company’s operations, financial performance and product development by reading this report: http://bit.ly/-IMSC-AnalystBrief

Sphere 3D Corp. (NASDAQ: ANY) is a provider of unified data management and data protection solutions across the data lifecycle. The company provides an integrated range of technologies and services for primary, nearline, offline, and archival data storage.

The company recently announced a merger with Overland Storage. Read the details of the merger and get updates on Overland’s products in the report that follows: http://bit.ly/-ANY-AnalystBrief

Our new alert CANF was by far the #1 gainer in the entire AMEX exchange until about 3-3:15 PM when it became obvious that after we hit the 75% gains mark at $4.30/share, profit taking dominated the remainder of the trading session. Congrats to those who obviously pulled profits along the way.

In our original report below we mentioned Roth Capital Analyst Report had issued a $15 price target last year. That was actually upgraded based on clinical results afterward to a $28 target.

Small Cap IR was the first firm to notify its members of CANF on 11-18-2014 with a full due diligence report before market open.

An analyst report which includes an overview of the company, financial and competitive analysis, analyst recommendation and price target can be viewed in its entirety by using the link below. There is no cost obligation required to view this report.

http://bit.ly/-CANF-AnalystValuation
 
About Small Cap IR
Once you have read our reports written by financial analysts you will understand that we make every effort to provide informative equity research reports for interested parties.

3rd party chartered financial analysts (CFA’s) provide a straightforward assessment of the profiled company and have pledged to remain free of influence when writing research reports. They include stocks traded in the NYSE, NASDAQ, and OTCBB exchanges.

Forward-Looking Disclaimer   
This report may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward- looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of mentioned company to be materially different from the statements made herein.   

Compliance Procedure   
Content is researched, written and reviewed on a best-effort basis by a 3rd party research analyst. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below. We do not engage in high frequency trading.

A full disclaimer can be found by viewing the analyst report.

If you wish to have a company covered in more detail by our team, or wish to learn more about our services, please contact us at [e-mail]. For any urgent concerns or inquiries please contact us at [e-mail].

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

Source: Small Cap IR

Contact: [e-mail]